PectaSol-C® Modified Citrus Pectin
Clinically proven to promote healthy prostate function & mercury detoxification

Special Dietary Usefulness
PectaSol® has been shown to support healthy prostate function and strengthen the immune system. PectaSol® is the only form of Modified Citrus Pectin that has been validated by human clinical trials

PectaSol-C® modified citrus pectin is a highly absorbable soluble dietary fiber. This natural product is derived from the pith of citrus fruits, and is modified utilizing an enhanced process resulting in improved molecular weight and chain characteristics.

PectaSol-C® product is recognized primarily for its ability to promote healthy cell growth and proliferation.

• Supports healthy cellular growth*
• Supports healthy immune function*
• Promotes prostate and breast health*
• Enhanced absorbability

PectaSolthe most effective form of Modified Citrus Pectin available!

• The only Modified Citrus Pectin (MCP) that has been validated by human clinical trials.
• More easily absorbed into the bloodstream than other forms of Pectin.
• PectaSol MCP is a carbohydrate that has been altered to form shorter chain molecules for better absorption through the digestive tract into the bloodstream.
• US patent protection (nos. 6,462,029 and
• 6,274,566) includes use of PectaSol in heavy metal chelation.*
• Manufactured in a manner that meets and exceeds GMP guidelines.
• Good tasting neutral flavor and easy to use. Dissolves readily at room temperature.

Features & Benefits
PectaSol® Modified Citrus Pectin (MCP) is designed to enhance immune function and maintain optimal health.* PectaSol® MCP has been clinically demonstrated to slow PSA doubling time in prostate cells.* It is known to promote normal cell growth by interfering with the binding properties of galectin proteins by preventing them from adhering to each other and the inner wall of blood vessels.* PectaSol® MCP is a complex polysaccharide (long-chain carbohydrate) obtained from the peel and pulp of citrus fruits and valued for its galactosyl component. It is modified to produce a shorter chain, low esterification pectin molecule which is more easily absorbed into the bloodstream. All the research on modified citrus pectin specifies a molecular weight of 10,000 to 20,000 daltons. PectaSol® meets this specification. The unique galactosyl component of PectaSol® MCP has an affinity for the binding galectin-3 sites, limiting the binding of certain cells to each other or blood vessels.*Citrus pectin is also recognized for its ability to promote cardiovascular health*.

More recent research indicates that Modified Citrus Pectin may also play an important role as a safe and effective heavy metal chelator. Isaac Eliaz, M.D., Medical Director of Amitabha Medical Clinic in Sebastopol, CA conducted a pilot human clinical trial to determine if MCP ia able to reduce the total body burden of mercury. The results demonstrated the MCP is capable of significantly decreasing the total body mercury burden in individuals after approximately four months. Their was a 69% mean average decrease in mercury burden, with the range of individual decreases being 38% to 75%. No significant side effects were noted. A possible mechanism of action may be that MCP exerts its heavy metal detoxification through gradient changes between the tissue and the blood stream.


PectaSol Modified Citrus Pectin is a complex polysaccharide (long chain carbohydrate) obtained from the peel and pulp of citrus fruits. It is rich in galactosyl subunits, which interfere with the binding properties of cell-surface proteins called galectin-3 molecules.* Galectin-3 are over-expressed in serious health conditions.

While ordinary pectin and some modified pectins also contain galactosyl subunits, only PectaSol Modified Citrus Pectin meets the specifications outlined in the published research. For this reason, PectaSol was selected for the first human clinical trials investigating the use of modified citrus pectin in lengthening prostate specific antigen doubling time (PSADT). PectaSol has demonstrated an ability to considerably slow the prostate specific antigen (PSA) doubling time in human clinical trials.

Quantity	Price